Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6,401,869
-
Total 13F shares
-
146,767
-
Share change
-
-85,200
-
Total reported value
-
$150,825
-
Price per share
-
$1.03
-
Number of holders
-
12
-
Value change
-
-$97,454
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of MAINZ BIOMED N.V. - Common Stock (MYNZ) as of Q1 2024
As of 31 Mar 2024,
MAINZ BIOMED N.V. - Common Stock (MYNZ) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
146,767 shares.
The largest 10 holders included
NORTHERN TRUST CORP, XTX Topco Ltd, Vontobel Holding Ltd., CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, Greenwich Investment Management, Inc., MORGAN STANLEY, UBS Group AG, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and NewEdge Advisors, LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.